retatrutide expanded access compassionate use eli lilly stock jumps on Phase 3 weight loss results Eli Lilly retatrutide Phase 3

Food and Drug Administration, serves as a critical pharmacovigilance tool for post-marketing surveillance of pharmaceutical products and therapeutic biologics 17

Conventional medicines have been discouraged due to their adverse effects and withdrawal symptoms

Astaxanthin: This potent carotenoid contributes to the antioxidant defense system, supporting reproductive health and protecting against oxidative stress

Overall, the results of this study indicate that LY3437943 has a safety and tolerability profile similar to other incretins, with pharmacokinetic and pharmacodynamic outcomes that support further clinical evaluation